Does ESTA pay a dividend and is it safe?

Establishment Labs Holdings Inc. (ESTA) offers a 0% cash dividend yield ($0.00 annualized) and 0.6% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

Stock Ratings / Health Care / ESTA / dividends

CDRE (62) ENOV (38) AVR (22) MSA (71) ⌘ Pro Terminal →

Establishment Labs Holdings Inc. (ESTA) Dividend Safety Gauge & 10-Year DRIP Compounder

$61.07 -2.22% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $60.71

Establishment Labs Holdings Inc. (ESTA) carries a Roarable Rating of E (Strong Sell) with 26/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E • RED ALERT Cap $1.86B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on ESTA Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is ESTA stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, Establishment Labs Holdings Inc. (NASDAQ: ESTA) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 26/100 at a spot price of $61.07 (-2.22% 1D, market cap $1.86B). Pillar breakdown: Fundamental Cash Engine 5/20, Institutional 13F & Options Flow 7/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 3/20, and Executive Insider Alignment 3/20. Active quantitative signal LIQUIDITY_TAILWIND (BEARISH, conviction undefined/100) notes: undefined.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does ESTA compare to CDRE and ENOV in the Health Care sector?

▼

Within the Health Care sector (Industrial Specialties), ESTA carries a Roarable E (26/100 RQD), trailing P/E of N/A, gross margin of 69.3%, and ROIC of -15.8%. By comparison, CDRE (Cadre Holdings Inc.) holds a C grade (62/100 RQD, P/E 30.2x, ROIC 11.0%, cap $1.30B) and ENOV (Enovis Corporation) posts a D- grade (38/100 RQD, P/E N/A, ROIC -32.7%, cap $1.15B). Among the 5-stock peer group, MSA leads on earnings multiple (24.8x) while MSA leads on capital efficiency (16.6% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for ESTA?

▼

Per ESTA's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001688757), Establishment Labs Holdings Inc. generated $211.1M in revenue (+27.1% YoY), -$51.1M in net income, and -$56.9M in free cash flow against $357.2M in total assets and $247.5M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $60.71 (-0.59%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 5/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (26/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-10.5% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • E

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk E

Each axis scored 0–20

12M PRICE TARGET CONE-14.4% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ESTA)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (26/100 Composite)

🔍 WHY ESTA SCORES 26/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (31% of score)

Altman Z-Score 2.52 (WATCH ZONE (1.8–3.0)) • Piotroski F-Score 5/9

▲ #2 Bullish Driver: Whale & Options Positioning+7/20 pts (27% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$58.45+4.5% Next Q

Q2 (-2Q)

Grade E$61.07+9.6% Next Q

Q3 (-1Q)

Grade E$66.95-8.8% Next Q

Current

Grade E$61.07-10.5% Hist 90D α

Trajectory: E (18) → E (26)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a ESTA Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While ESTA currently carries a cautious 26/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($66.79) and Max Pain ($64.12) forces dealer call-delta covering toward $102.47.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $ESTA• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “ESTA Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 26%NO 74%Trade / Inspect Odds →

CASH DIVIDEND + BUYBACK YIELD

0.6% Total Yield

0% Cash ($0.00/yr) + 0.6% Buybacks

PAYOUT SAFETY SPEEDOMETER

74/100 • REINVESTING IN GROWTH + BUYBACKS

FREE CASH FLOW PAYOUT RATIO

0% (100% Reinvested)

Retains cash flow for R&D and share repurchases

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (15.1% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $40,809

Est. Year-10 Shareholder Yield: $245/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$11.5K

Yr 1

$13.2K

Yr 2

$15.2K

Yr 3

$17.6K

Yr 4

$20.2K

Yr 5

$23.3K

Yr 6

$26.8K

Yr 7

$30.8K

Yr 8

$35.5K

Yr 9

$40.8K

Yr 10

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ESTA)

✓Walkthrough of ESTA's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

ESTA // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -13.06%▼ DESCENDING CHANNEL

2026-11-03O $68.41H $68.41L $61.07C $61.07VOL 1.03M

RES: $71.53SUP: $49.60SMA50: $66.79SMA200: $72.37

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ESTA Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 ESTA Butterfly Map → + Track ESTA →

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle

8.0%/yr Implied 5Y Growth

vs. +27.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on ESTA today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ESTA. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for ESTA today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ESTA)

Health Care Rank #902 of 1015 ⚔️ CDRE vs ESTA Full Matrix →

1. Head-to-Head Health Care Peer Comparison (ESTA vs. CDRE, ENOV, AVR, MSA)

Industry: Industrial Specialties (55 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, Establishment Labs Holdings Inc. (ESTA) ranks #902 by composite RQD confidence (26/100, grade E) and #267 by equity capitalization ($1.86B). Within this direct 5-issuer industry benchmark cohort, MSA leads on earnings valuation at 24.8x trailing P/E, while MSA leads on capital efficiency and profitability with 16.6% ROIC and 46.5% gross margin. MSA currently holds the highest overall quantitative score in the immediate peer group at 71/100 (B-) compared with ESTA at 26/100 (E).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
ESTA ACTIVE Establishment Labs Holdings Inc.	E	26/100	—	69.3%	-15.8%	-2.22%	$1.86B	Benchmark Subject
CDRE Cadre Holdings Inc.	C	62/100	30.2x	42.5%	11.0%	+3.79%	$1.30B	/cdre-vs-esta →
ENOV Enovis Corporation	D-	38/100	—	59.8%	-32.7%	+3.57%	$1.15B	/enov-vs-esta →
AVR Anteris Technologies Global Corp.	E	22/100	—	70.3%	-35.0%	-8.40%	$615.2M	/avr-vs-esta →
MSA MSA Safety Incorporated	B-	71/100	24.8x	46.5%	16.6%	+4.41%	$6.89B	/msa-vs-esta →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001688757 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Establishment Labs Holdings Inc. (ESTA) reported GAAP revenue of $211.1M (+27.1% vs. FY2024 revenue of $166.0M , and +27.8% cumulative change since FY2023) , GAAP net income of -$51.1M, operating cash flow of -$50.9M, and free cash flow of -$56.9M (+11.9% YoY). On the balance sheet, ESTA closed FY2025 with $357.2M in total assets against $247.5M in total debt (Altman Z-Score: 2.52, Piotroski F-Score: 5/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$211.1M	-$51.1M	-$50.9M	-$56.9M	$357.2M	$247.5M
FY2024 (FY)	2024-12-31	$166.0M	-$84.6M	-$58.5M	-$64.6M	$346.8M	$219.6M
FY2023 (FY)	2023-12-31	$165.2M	-$78.5M	-$88.5M	-$88.5M	—	—

3. ESTA Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ESTA stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does ESTA compare to CDRE and ENOV in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for ESTA?

Where is ESTA trading relative to its 50-day, 200-day, and 52-week technical levels?

ESTA last traded at $61.07 (-2.22% on volume of 708,371 shares), positioning the stock -8.56% below its 50-day simple moving average ($66.79) and -15.61% below its 200-day simple moving average ($72.37). Across its 52-week range of $47.00 to $97.59, ESTA sits at the 27.8% percentile with a 14-day RSI of 46.0 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($53.44 to $68.70).

Direct Sub-Reports: ESTA RQD Cockpit ESTA 12M Forecast ESTA Earnings & Move ESTA Dividends & DRIP ESTA Insiders & 13F ESTA Whale Options ESTA Profit Sankey ESTA News & Why

ROARABLE RATING BRIEF • RQD 26/100 (E) ✓ SEC XBRL & RQD VERIFIED

ESTA — Establishment Labs Holdings Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit

Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Establishment Labs Holdings Inc. (ESTA) earns a live Roarable RQD composite score of 26/100, corresponding to a E letter grade (Roarable Strong Sell) at a spot price of $61.07 (-2.22% 1D, market capitalization $1.86B).

Fundamental Cash Engine (5/20): Anchored by return on invested capital (ROIC) of -15.8%, gross margin of 69.3%, operating margin of -18.5%, and free cash flow yield of -2.79%.
Whale 13F & Options Flow (7/20) + Insider Conviction (3/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
Macro Regime Fit (3/20) + Forensic Balance Sheet (8/20): Incorporates a 1.00x equity beta, Altman Z-Score of 2.52, Piotroski F-Score of 5/9, and Debt/Equity of 8.50x.

2. Business Model, Unit Margins & SEC Financial Trajectory

Establishment Labs Holdings Inc. Is a NASDAQ-listed issuer in the Health Care sector, within the Industrial Specialties industry. The company reported FY 2025 revenue of $211.1M and a gross margin of 69.3% per the market data.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Establishment Labs Holdings Inc. (ESTA) reported $211.1M in annual revenue (up from $166.0M in FY2024, +27.1% YoY) and -$51.1M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($165.2M revenue, -$78.5M net income) through FY2025, ESTA scaled operating cash flow to -$50.9M and free cash flow to -$56.9M, backed by $357.2M in total assets against $247.5M in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

🐂 Primary Bull Case (E • RQD 26/100): Established market leader in Health Care with deep daily trading liquidity. Free cash flow yield of -2.79% and institutional whale pillar of 7/20. With Fundamental Cash Engine at 5/20 and Institutional Whale Flow at 7/20, sustained execution supports upside toward the upper end of the $47.00 – $97.59 52-week range.
🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -18.5% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Upstream and downstream dependency detail is — The sector correlation captured is to liquidity conditions: the stock's 1.88x elasticity to Net Liquidity means tightening in the Fed balance sheet, Treasury General Account, or overnight RRP would be a second-order pressure point. A widening high-yield spread (+2 bps per the graph) is a further monitoring item for funding conditions.

Key Question #1: Can ESTA sustain or expand its -18.5% operating margin and -15.8% ROIC against Industrial Specialties peers over the next 4 quarters?
Key Question #2: Following FY2025 revenue of $211.1M and free cash flow of -$56.9M, how will capital allocation balance growth reinvestment against $247.5M in total debt?
Key Question #3: How sensitive is ESTA's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

ESTA Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Establishment Labs Holdings Inc. (ESTA) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to ESTA Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo! Finance Canada • 22h ago

Establishment Labs Holdings Inc. (ESTA) Stock Price, News, Quote & History

Yahoo! Finance Canada report covering Establishment Labs Holdings Inc. (ESTA) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Yahoo Finance • 1d ago

Establishment Labs Holdings (ESTA) Wins Expanded FDA Clearance, Is The Stock Still A Bargain?

Yahoo Finance report covering Establishment Labs Holdings Inc. (ESTA) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Investing.com • 1d ago

Establishment Labs stock price target lowered to $93 by BTIG on estimates

Investing.com report covering Establishment Labs Holdings Inc. (ESTA) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE TradingView • 1d ago

Establishment Labs Holdings Inc. Estimates – NASDAQ:ESTA

TradingView report covering Establishment Labs Holdings Inc. (ESTA) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Simply Wall St • 1d ago

Establishment Labs Holdings (ESTA), Why Is It Getting Attention Today?

Simply Wall St report covering Establishment Labs Holdings Inc. (ESTA) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Investing.com • 1d ago

Mizuho reiterates Establishment Labs stock rating on strong sales

Investing.com report covering Establishment Labs Holdings Inc. (ESTA) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Yahoo Finance • 1d ago

Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Beats Revenue Estimates

Yahoo Finance report covering Establishment Labs Holdings Inc. (ESTA) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Simply Wall St • 1d ago

Earnings Beat Might Change The Case For Establishment Labs Holdings Stock

Simply Wall St report covering Establishment Labs Holdings Inc. (ESTA) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

ESTA Bull vs. Bear Conversation Board — What's Your Call at $61.07?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON ESTA 🐻 33% BEARISH CONVICTION

QU QuantViper RQD DEBATE OPENER • Systematic Momentum Desk 🐂 BULLISH 🎯 Target: $78.70 (+26.0%)

📌 Pinned Debate

Institutional accumulation and options positioning score 11 of 20, the strongest RQD pillar, and revenue grew from $165.2M to $211.1M o

Long ESTA at $62.46 targeting $78.70. Institutional accumulation and options positioning score 11 of 20, the strongest RQD pillar, and revenue grew from $165.2M to $211.1M over two years.. Institutional whale score is 7/20 and the risk/reward vs. the $47.00 52-week low is skewed heavily in favor of bulls.

VolSurface_Trader 🐂 BULL

@MeanReversion_88 Shorting a 7/20 institutional whale-flow stock at $62.46 is dangerous when funds are rotating into Health Care.

ME MeanReversion_88 RQD DEBATE OPENER • Quantitative Statistical Arb 🐻 BEARISH 🎯 Target: $49.34 (-21.0%)

Spot @ $62.46

ROIC of -15.8%, FCF yield of -2.79%, and a 1.88x Net Liquidity elasticity leave the stock exposed to both weak cash generation and liqu

Fading this rally in ESTA at $62.46. ROIC of -15.8%, FCF yield of -2.79%, and a 1.88x Net Liquidity elasticity leave the stock exposed to both weak cash generation and liquidity tightening.. With a beta of 1.0 and the stock sitting at $62.46 (52-wk range $47.00–$97.59), the easy multiple expansion is already priced in.